Request Info / Demo
Back to all
Artificial Intelligence Across Pharmacovigilance: Fad or Reality?

Artificial Intelligence Across Pharmacovigilance: Fad or Reality?

News
29/03/17

MyMeds&Me CEO Andrew Rut writes for the newly released Clinical & Contract Research Association (CCRA) yearbook, to analyse and discuss how artificial intelligence and machine learning might influence the future of pharmacovigilance study.

Read more in the CCRA Industry Yearbook 2017

MyMeds&Me and CCRA Yearbook - Artificial Intelligence Across Pharmacovigilance: Fad or Reality?

You may also be interested in

COVID-19 Therapeutics and Vaccines Are Here: What All Companies Need to Do Next
News

COVID-19 Therapeutics and Vaccines Are Here: What All Companies Need to Do Next
Brexit can spark a Big Bang for life sciences - Dr. Andrew Rut in City AM
News

Brexit can spark a Big Bang for life sciences - Dr. Andrew Rut in City AM
Dr Andrew Rut discusses the importance of quality data in Enterprise Times
News

Dr Andrew Rut discusses the importance of quality data in Enterprise Times
Article - MyMeds&Me acquisition paves path for pharmacovigilance expansion
News

Article - MyMeds&Me acquisition paves path for pharmacovigilance expansion

Request More Information

To find out more or request a demo fill in the details below:

By submitting your information, you are consenting to receive communications from MyMeds&Me. You may at any time 'opt out' of receiving these marketing communications by emailing info@mymedsandme.com.
  • ©2012–2024 MyMeds&Me. Registered in England & Wales under registration no. 07660726
  • 2 Crossways Business Centre, Bicester Road, Aylesbury, HP18 0RA
  • Web Design North Wales

Cookies

We use analytical cookies that need your permission. For more details and advanced options view our Cookies Policy.

DeclineAccept